This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Your saved search

Name of saved search:

Search terms:

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2005 Nov 24;438(7067):420-1.

doi: 10.1038/438420a.

No authors listed

No authors listed. Nature. 2005.

. 2005 Nov 24;438(7067):420-1.

doi: 10.1038/438420a.

No abstract available

Enforcing pharmaceutical and biotech patent rights in China.
Zhang YP, Deng MM. Zhang YP, et al. Nat Biotechnol. 2008 Nov;26(11):1235-40. doi: 10.1038/nbt1108-1235. Nat Biotechnol. 2008. PMID: 18997760 No abstract available.
Intellectual property rights.
Ogle W. Ogle W. Science. 2000 May 19;288(5469):1173-4. Science. 2000. PMID: 10841736 No abstract available.
[From intellectual property to commercial property].
Cappelaere P. Cappelaere P. Bull Cancer. 2005 Apr;92(4):297-8. Bull Cancer. 2005. PMID: 15888384 French. No abstract available.
The interaction between intellectual property and drug regulatory systems: global perspectives.
Madden EA. Madden EA. IDrugs. 2007 Feb;10(2):116-20. IDrugs. 2007. PMID: 17285464 Review.
Gene patenting and medical research: a view from a pharmaceutical company.
Stott M, Valentine J. Stott M, et al. Nat Rev Drug Discov. 2004 Apr;3(4):364-8. doi: 10.1038/nrd1348. Nat Rev Drug Discov. 2004. PMID: 15060532 Review. No abstract available.